Aclaris Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q4 2015 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Aclaris Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2015 to Q3 2024.
  • Aclaris Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 31, 2024 was 71.4M shares, a 0.84% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 71.4M +595K +0.84% Oct 31, 2024 10-Q 2024-11-06
Q2 2024 71.3M +550K +0.78% Jul 31, 2024 10-Q 2024-08-07
Q1 2024 71.3M +585K +0.83% Apr 30, 2024 10-Q 2024-05-07
Q4 2023 70.9M +4.23M +6.35% Jan 31, 2024 10-K 2024-02-27
Q3 2023 70.8M +4.15M +6.23% Oct 31, 2023 10-Q 2023-11-06
Q2 2023 70.8M +4.12M +6.18% Jul 31, 2023 10-Q 2023-08-07
Q1 2023 70.7M +4.1M +6.15% Apr 28, 2023 10-Q 2023-05-08
Q4 2022 66.7M +5.42M +8.84% Jan 31, 2023 10-K 2023-02-23
Q3 2022 66.7M +5.46M +8.91% Oct 31, 2022 10-Q 2022-11-08
Q2 2022 66.7M +5.46M +8.91% Jul 29, 2022 10-Q 2022-08-03
Q1 2022 66.6M +14.5M +27.8% Apr 29, 2022 10-Q 2022-05-10
Q4 2021 61.3M +9.47M +18.3% Jan 31, 2022 10-K 2022-02-24
Q3 2021 61.2M +18.3M +42.7% Oct 29, 2021 10-Q 2021-11-02
Q2 2021 61.2M +18.5M +43.3% Jul 30, 2021 10-Q 2021-08-05
Q1 2021 52.1M +10.2M +24.5% Apr 30, 2021 10-Q 2021-05-07
Q4 2020 51.8M Jan 31, 2021 10-K 2021-02-25
Q3 2020 42.9M +1.53M +3.7% Oct 31, 2020 10-Q 2020-11-04
Q2 2020 42.7M +1.35M +3.27% Aug 6, 2020 10-Q 2020-08-07
Q1 2020 41.9M +597K +1.45% May 1, 2020 10-Q 2020-05-07
Q3 2019 41.4M +452K +1.11% Nov 7, 2019 10-Q 2019-11-07
Q2 2019 41.4M +10.4M +33.5% Aug 5, 2019 10-Q 2019-08-08
Q1 2019 41.3M +10.4M +33.6% Mar 15, 2019 10-K 2019-03-18
Q3 2018 40.9M +10.1M +32.8% Nov 5, 2018 10-Q 2018-11-06
Q2 2018 31M +4.24M +15.9% Aug 2, 2018 10-Q 2018-08-03
Q1 2018 30.9M +4.81M +18.4% Mar 9, 2018 10-K 2018-03-12
Q3 2017 30.8M +9.4M +43.9% Nov 6, 2017 10-Q 2017-11-07
Q2 2017 26.7M +5.32M +24.8% Aug 7, 2017 10-Q 2017-08-08
Q1 2017 26.1M +5.93M +29.4% Mar 14, 2017 10-K 2017-03-15
Q3 2016 21.4M Nov 2, 2016 10-Q 2016-11-03
Q2 2016 21.4M Aug 10, 2016 10-Q 2016-08-11
Q1 2016 20.2M Mar 23, 2016 10-K 2016-03-23
Q4 2015 20.2M Nov 17, 2015 10-Q/A 2015-12-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.